Stages of AMD

There are two types of age-related macular degeneration (AMD), usually described as either “dry” or “wet” (see Figure below). Both types of AMD can cause severe vision loss, affecting central vision but sparing the peripheral (side) vision.1,2 Earlier diagnosis and appropriate treatment help maintain better vision.3

  • “Dry” (atrophic, or non-exudative) AMD:4,5 In the dry type of AMD, areas of the macula get thinner (atrophy), and deposits of fats and protein, called drusen, develop under the tissues of the retina.4,5 Approximately 80% of people with AMD have the dry form, which can slowly progress to late- (geographic atrophy, meaning the cells in the center of the retina are getting thinner) or end-stage disease.2 Sometimes, people with dry AMD can develop the “wet” advanced form in later disease.1-3,6-8
  • Wet” (neovascular, or exudative) AMD: In the wet type of AMD, abnormal blood vessels (neovascular means new blood vessels) grow under the tissues of the retina.4,5 These abnormal blood vessels can leak blood or other fluid (exudates), causing scarring of the macula.4 Although the wet form is less common, vision loss can be faster and more severe; about 90% of cases of legal blindness caused by AMD are due to this form.2

References

  1. CDC. About Age-Related Macular Degeneration. Vision and Eye Health. May 15, 2024. https://www.cdc.gov/vision-health/about-eye-disorders/age-related-macular-degeneration.html
  2. Flaxel CJ, Adelman RA, Bailey ST, et al. Age-Related Macular Degeneration Preferred Practice Pattern®. Ophthalmology. 2020;127:P1-P65.
  3. Rein DB, Wittenborn JS, Burke-Conte Z, et al. Prevalence of age-related macular degeneration in the US in 2019. JAMA Ophthalmol. 2022;140:1202-1208.
  4. Boyd K. What Is Macular Degeneration? American Academy of Ophthalmology. November 13, 2023. https://www.aao.org/eye-health/diseases/amd-macular-degeneration
  5. Porter D. What Are Drusen? American Academy of Ophthalmology. September 11, 2024. https://www.aao.org/eye-health/diseases/what-are-drusen
  6. Fernandes AR, Zielińska A, Sanchez-Lopez E, et al. Exudative versus nonexudative age-related macular degeneration: Physiopathology and treatment options. Int J Mol Sci. 2022;23:2592.
  7. Mehta S. Age-Related Macular Degeneration (AMD or ARMD) – Eye Disorders. Merck Manual Professional Edition. April 2024. https://www.merckmanuals.com/en-ca/professional/eye-disorders/retinal-disorders/age-related-macular-degeneration-amd-or-armd
  8. Cunningham J. Recognizing age-related macular degeneration in primary care. JAAPA. 2017;30:18-22.
  9. AMDF. Dry Age-related Macular Degeneration. https://www.macular.org/about-macular-degeneration/dry-macular-degeneration
  10. AMDF. Wet Age-related Macular Degeneration. https://www.macular.org/about-macular-degeneration/wet-macular-degeneration
  11. Ferris FL, Wilkinson CP, Bird A, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844-851.
  12. Flores R, Carneiro Â, Vieira M, Tenreiro S, Seabra MC. Age-related macular degeneration: Pathophysiology, management, and future perspectives. Ophthalmologica. 2021;244:495-511.
  13. VanDenLangenberg AM, Carson MP. Drusen Bodies. StatPearls. Last update May 1, 2023. https://www.ncbi.nlm.nih.gov/books/NBK559087/
All URLs accessed October 1, 2024.

Pin It on Pinterest

Directory

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Patient & Caregiver Educational Resources

The RELIEF Patient Toolkit is a resource center for patients who have been diagnosed with or who are interested in learning about age-related macular degeneration (AMD). Choose from the options below to learn more.

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | AMD Relief | All Rights Reserved | Website by Divigner